Hodgkin lymphoma: open trials in Brazil

• NCT07519772

  A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  Hospital Erasto Gaertner (Site 1503), Curitiba · Hospital Paulistano (Site 1504), São Paulo · Hospital das Clinicas FMUSP (Site 1502), São Paulo

  Registry updated 2026-10-29

• NCT06526793

  Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  Trial Treatment · Phase 2 · AstraZeneca

  Porto Alegre · São Paulo

  Registry updated 2026-10-14

• NCT06137144

  AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  Trial Treatment · Phase 1/2 · AstraZeneca

  São Paulo

  Registry updated 2026-10-13

• NCT02332668

  A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

  Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC

  MSD Brasil, São Paulo

  Registry updated 2026-07-06

• NCT06299462

  PTCy and ATG for MSD and MUD Transplants

  Trial Treatment · Phase 1/2 · Instituto Nacional de Cancer, Brazil

  Instituto Nacional de Câncer, Rio de Janeiro

  Registry updated 2025-02-25

All Hodgkin lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error